Currently out of the existing stock ratings of David Maris, 57 are a BUY (53.27%), 42 are a HOLD (39.25%), 8 are a SELL (7.48%).

David Maris

Work Performance Price Targets & Ratings Chart

Analyst David Maris works at WELLS FARGO with a stock forecast success ratio of 51.52% fulfilled within 229.8 days on average. Previously, David Maris worked at BMO.

David Maris’s has documented 213 price targets and ratings displayed on 15 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on TEVA, Teva Pharma Industries Ltd ADR at 28-Oct-2021.

Wall Street Analyst David Maris

Analyst best performing recommendations are on MNK (MALLINCKRODT PLC).
The best stock recommendation documented was for MNK (MALLINCKRODT PLC) at 11/8/2017. The price target of $22 was fulfilled within 1 day with a profit of $2.02 (10.11%) receiving and performance score of 101.1.

Average potential price target upside

AGN Allergan plc EBS Emergent Biosolutions MNK Mallinckrodt plc MYL Viatris PRGO Perrigo Company PLC TEVA Teva Pharma Industries Ltd ADR BHC Bausch Health Companies JAZZ Jazz Pharmaceuticals PLC FLXN Flexion Therapeutics IRWD Ironwood Pharmaceuticals NEOS Neos Therapeutics VTRS Viatris AMPH Amphastar P MDWD Mediwound Ltd SIEN Sientra

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

193

$-0.02 (-0.01%)

3 years 10 months 1 days ago

2/7 (28.57%)

$8.96 (4.87%)

35

Buy

203

4 years 5 days ago

1/2 (50%)

$20.22 (11.61%)

95

Hold

203

$9.98 (5.17%)

178

4 years 12 days ago

5/15 (33.33%)

$3.35 (1.68%)

63

Hold

157

$-36.02 (-18.66%)

161

4 years 6 months 15 days ago

11/12 (91.67%)

$-1.84 (-1.16%)

201

165

$-28.02 (-14.52%)

125

4 years 6 months 15 days ago

5/6 (83.33%)

$6.16 (3.88%)

95

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by David Maris?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?